SEC Form D private-offering filing

Triton Therapeutics, Inc.

Name: Triton Therapeutics, Inc. - new SEC Form D private-offering filing, Stamford, CT
Published: 2025-10-23

A new SEC Form D private-offering notice from Stamford, CT, a $36,355,769 filer-stated offering target in Biotech. The source filing is one click away.

Triton Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing first in class medicines for autoimmune and fibrotic diseases.

Filed 2025-10-23Filed to raise $36,355,769First money in 2025-10-17Raised so far $36,355,769HQ (as filed) Stamford, CTSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified tritonthera.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in Connecticut →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.